Quantum-Si (NASDAQ:QSI – Get Free Report) will likely be announcing its Q2 2026 results after the market closes on Tuesday, August 4th. Analysts expect the company to announce earnings of ($0.13) per share and revenue of $0.3020 million for the quarter. Individuals can find conference call details on the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Thursday, August 13, 2026 at 4:30 PM ET.
Quantum-Si (NASDAQ:QSI – Get Free Report) last released its quarterly earnings results on Thursday, May 7th. The company reported ($0.10) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.12) by $0.02. Quantum-Si had a negative net margin of 5,605.88% and a negative return on equity of 47.35%. The company had revenue of $0.26 million for the quarter, compared to the consensus estimate of $0.30 million. On average, analysts expect Quantum-Si to post $-0 EPS for the current fiscal year and $-0 EPS for the next fiscal year.
Quantum-Si Stock Performance
QSI stock traded down $0.04 during trading on Tuesday, hitting $0.75. 674,579 shares of the company’s stock traded hands, compared to its average volume of 4,882,289. Quantum-Si has a 52 week low of $0.69 and a 52 week high of $3.10. The stock has a market capitalization of $162.45 million, a price-to-earnings ratio of -1.46 and a beta of 3.20. The business has a fifty day simple moving average of $0.95 and a 200 day simple moving average of $0.97.
Hedge Funds Weigh In On Quantum-Si
Wall Street Analyst Weigh In
Separately, Weiss Ratings raised Quantum-Si from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Tuesday, July 21st. One analyst has rated the stock with a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Quantum-Si has an average rating of “Reduce” and a consensus price target of $1.00.
View Our Latest Stock Report on QSI
Quantum-Si Company Profile
Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.
Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.
Featured Articles
- Five stocks we like better than Quantum-Si
- 5 Space Stocks Face a Brutal Correction: Which Ones Are Still Buys?
- Whirlpool’s Report May Show How Frozen the Housing Market Really Is
- 3 Stocks Standing Out and 2 Losing Momentum as the Tech Rally Cracks
- 5 AI Stocks Are Pulling Back—Which Growth Catalysts Still Look Strongest?
Receive News & Ratings for Quantum-Si Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantum-Si and related companies with MarketBeat.com's FREE daily email newsletter.
